Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging.
about
Efficacy and safety of the combination of paclitaxel and platinum in advanced thymic carcinoma.Stage IVb thymic carcinoma: patients with lymph node metastases have better prognoses than those with hematogenous metastasesExpression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.Multimodality treatment of stage II thymic tumours.Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progression.
P2860
Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Clinical characteristics and o ...... evaluation of Masaoka staging.
@ast
Clinical characteristics and o ...... evaluation of Masaoka staging.
@en
type
label
Clinical characteristics and o ...... evaluation of Masaoka staging.
@ast
Clinical characteristics and o ...... evaluation of Masaoka staging.
@en
prefLabel
Clinical characteristics and o ...... evaluation of Masaoka staging.
@ast
Clinical characteristics and o ...... evaluation of Masaoka staging.
@en
P2093
P2860
P1476
Clinical characteristics and o ...... evaluation of Masaoka staging.
@en
P2093
Andre L Moreira
Andreas Rimner
Anya M Litvak
Camelia S Sima
Gregory J Riely
Kaitlin Woo
Maria Tsukazan
Sara Hayes
P2860
P304
P356
10.1097/JTO.0000000000000363
P50
P577
2014-12-01T00:00:00Z